Avi Dor

Professor of Health Policy
George Washington University

Avi Dor, a health economist, is a Professor in the Department of Health Policy and Management at the Milken Institute School of Public Health, George Washington University (GWU), and Director of its Health Economics and Health Policy PhD Programs. He is highly experienced in large data base analysis and econometric modeling of health care costs and outcomes, pharmaceutical pricing, and well as cost-effectiveness in applied health care settings. His research has been published in leading economics journals (e.g., American Economic Review, European Economic Review), leading field journals (e.g., Journal of Health Economics, Journal of Regulatory Economics, JEMS), medical journals (e.g., NEJM, JAMA, Cancer), major health policy journals (Health Affairs, Health Services Research, Inquiry). 

Avi Dor has consulted for a variety of organizations, including the World Bank, Amgen, GlaxoSmithKline, and Teva Pharmaceuticals, and patient advocacy organizations. In addition, he frequently serves on NIH and AHRQ grant review panels. His work has been cited by major media and trade press outlets including the New York Times, CNN, NPR, US News and World Report, Modern Healthcare, and Kaiser Health News. Dr. Dor’s other affiliation include the National Bureau of Economic Research (NBER), and a joint faculty appointments at the GWU Trachtenberg School of Public Policy.


Childhood vaccines play a major role in minimizing the incidence of vaccine-preventable disease. While all states accommodate medical vaccine exemptions, certain states also allow for waivers on the basis of religious or philosophical objections.


Showing 1 - 1 of 1

The rising rate of non-medical exemptions is a driving force behind our nationwide measles crisis. Chelsea J. Richwine, Avi Dor, and Ali Moghtaderi of George Washington University examine the effect of California’s 2016 decision to repeal all non-medical exemptions on immunization coverage in a new working paper.